戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ismatched donor, alemtuzumab, anti-thymocyte antiglobulin, and acute and chronic graft versus host di
2                 The method uses biotinylated antiglobulin bound to streptavidin-coated microtiter pla
3 t patients, B cell donor cross-matches using antiglobulin complement-dependent cytotoxicity or flow c
4 A-select frozen T-lymphocyte panel using the antiglobulin cytotoxicity technique.
5 Cross-linking of non-FcR-binding variants by antiglobulin enhanced TCR internalization and minimized
6 monthly by ELISA (13.9 tests/patient) and by antiglobulin-enhanced panel reactivity (6.3 tests/patien
7 ere performed using lymphocyte cytotoxicity (antiglobulin-enhanced, complement-dependent cytotoxicity
8 stribution, pharmacokinetics, dosimetry, and antiglobulin formation were evaluated.
9 tometry was slightly more sensitive than the antiglobulin method and considerably more sensitive than
10                                              Antiglobulin responses are a significant limitation to t
11                                           No antiglobulin responses were detected in 30 patients give
12                    PRA was determined by the antiglobulin technique and flow cytometry.
13 measured PRA for class I antibodies with the antiglobulin technique increased to 43+/-36% at 1 month
14 tibody concentration is measured by indirect antiglobulin technique titration, or where possible (for
15  prognostic impact of both a positive direct antiglobulin test (DAT) and AHA.
16 splant recipient developed a positive direct antiglobulin test (DAT), with anti-A eluted, and severe
17  at their blood center had a positive direct antiglobulin test (DAT).
18 or whose erythrocytes have a positive direct antiglobulin test 3) to determine which phenotypically F
19                 In AIHA, in which the direct antiglobulin test detects primarily C3 rather than immun
20 se, 8% mixed, and 5% atypical (mostly direct antiglobulin test negative).
21 ting, gestational age, and results of direct antiglobulin testing.
22                             As with indirect antiglobulin tests (IAT), which use IgG antibodies for d
23 e asplenic (P<0.001) and had positive direct antiglobulin tests for IgG and complement component 3; w
24 irubinemia group, those with positive direct antiglobulin tests had lower scores on cognitive testing
25                                              Antiglobulin to murine antibody and to streptavidin deve